MRPL23 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.970560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.056200E-01
Normal-vs-Stage2
2.083200E-01
Normal-vs-Stage3
5.858000E-01
Normal-vs-Stage4
1.539830E-01
Stage1-vs-Stage2
5.349400E-01
Stage1-vs-Stage3
4.202000E-01
Stage1-vs-Stage4
4.161600E-01
Stage2-vs-Stage3
4.723200E-01
Stage2-vs-Stage4
7.088200E-01
Stage3-vs-Stage4
7.549000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.914450E-01
Normal-vs-AfricanAmerican
6.551000E-01
Normal-vs-Asian
1.343040E-01
Caucasian-vs-AfricanAmerican
2.379600E-01
Caucasian-vs-Asian
4.732400E-02
AfricanAmerican-vs-Asian
1.067170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.680240E-01
Normal-vs-Female
2.508000E-01
Male-vs-Female
6.484400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.875590E-01
Normal-vs-Age(41-60Yrs)
2.256400E-01
Normal-vs-Age(61-80Yrs)
2.005800E-01
Normal-vs-Age(81-100Yrs)
1.894650E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.208800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.827600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.784000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.022800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.196400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.605800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.102000E-01
Normal-vs-Daily Drinker
1.433410E-01
Normal-vs-Weekly Drinker
1.953230E-01
Normal-vs-Occasional Drinker
3.282200E-02
Normal-vs-Social Drinker
2.120400E-01
Non Drinker-vs-Daily Drinker
6.692000E-01
Non Drinker-vs-Weekly Drinker
9.654200E-01
Non Drinker-vs-Occasional Drinker
5.659000E-01
Non Drinker-vs-Social Drinker
5.899600E-01
Daily Drinker-vs-Weekly Drinker
7.490200E-01
Daily Drinker-vs-Occasional Drinker
9.014200E-01
Daily Drinker-vs-Social Drinker
3.559200E-01
Weekly Drinker-vs-Occasional Drinker
6.252000E-01
Weekly Drinker-vs-Social Drinker
5.880800E-01
Occasional Drinker-vs-Social Drinker
2.124400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.700600E-01
Normal-vs-Grade 2
1.265180E-01
Normal-vs-Grade 3
1.154840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.875800E-01
Grade 1-vs-Grade 3
7.048400E-01
Grade 1-vs-Grade 4
2.700600E-01
Grade 2-vs-Grade 3
9.936800E-01
Grade 2-vs-Grade 4
1.265180E-01
Grade 3-vs-Grade 4
1.154840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.184200E-01
Normal-vs-NonDiabetic
1.345980E-01
Diabetic-vs-NonDiabetic
7.552800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.052220E-01
Normal-vs-NoPancreatitis
1.771250E-01
Pancreatitis-vs-NoPancreatitis
4.685500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.253810E-01
Normal-vs-N1
2.302400E-01
N0-vs-N1
1.978300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.154210E-01
Normal-vs-TP53-NonMutant
2.957400E-01
TP53-Mutant-vs-TP53-NonMutant
3.366300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
